Compounds, compositions and methods
AssigneeDenali Therapeutics Inc.
InventorsRobert A. Craig, II, Javier de Vicente Fidalgo, Anthony A. Estrada, Jianwen A. Feng, Katrina W. Lexa, Maksim Osipov, Zachary K. Sweeney, Arun Thottumkara
Life of this patent
Estimating the term…
Abstract
The present disclosure relates generally to eukaryotic initiation factor 2B modulators, or a pharmaceutically acceptable salt, stereoisomer, mixture of stereoisomers, or prodrug thereof, and methods of making and using thereof.
Claims50
A compound of Formula I:
- or a pharmaceutically acceptable salt, isotopically enriched analog, stereoisomer, mixture of stereoisomers or prodrug thereof, wherein:
- p is 0, 1, 2, 3, 4, 5 or 6;
- L is heteroaryl optionally substituted with one to six R13, or a linker of Formula i:
- where bond a is attached to the tetrahydropyran and bond b is attached to R3;
- X is O, NR7, or a bond;
- z is 0 or 1;
- R1 is C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl, each of which is optionally substituted with one to five R11;
- R2 is hydrogen, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl, each of which, other than hydrogen, is optionally substituted with one to five R11;
- or R1 and R2, together with the nitrogen atom to which they are attached, join to form a heterocyclyl or heteroaryl, each of which is optionally substituted with one to five R11;
- R3 is C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl, each of which is optionally substituted with one to six R11;
- R4 and R5 are independently hydrogen, C1-12 alkyl, C2-12 alkenyl or C2-12 alkynyl, each of which, other than hydrogen, is independently optionally substituted with one to five R11;
- or R4 and R5, together with the atoms to which they are attached, join to form a C3-10 cycloalkyl or heterocyclyl, each of which is optionally substituted with one to five R11;
- R6 is hydrogen, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, or heterocyclyl, each of which, other than hydrogen, is optionally substituted with one to three R11;
- or R4 and R6, together with the atoms to which they are attached, join to form a heterocyclyl, which is optionally substituted with one to five R11;
- R7 is hydrogen, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, or heterocyclyl, each of which, other than hydrogen, is optionally substituted with one to three R11;
- or R4 and R7, together with the atoms to which they are attached, join to form a heterocyclyl, which is optionally substituted with one to five R11;
- each R8 is independently halo, cyano, —NR16R17, C1-6 alkyl, C1-6 alkoxy, or C1-6 haloalkyl, or two R8 attached to the same atom, together form a C(O) or spiro C3-6 cycloalkyl, or two R8 attached to different atoms, together with the atoms to which they are attached, form a fused C3-6 cycloalkyl or a C1-3 alkylene bridge, wherein each C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, C3-6 cycloalkyl or C1-3 alkylene bridge of R8 is optionally substituted with one to six R10;
- each R10 is independently halo, hydroxy, C1-6 alkyl, or C1-6 haloalkyl;
- each R11 is independently halo, cyano, nitro, oxo, —OR16, —SR16, —SF5, —NR16R17, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, heterocyclyl, aryl, heteroaryl, —C(O)R16, —C(O)OR16, —OC(O)OR16, —OC(O)R16, —C(O)NR16R17, —OC(O)NR16R17, —NR16C(O)NR16R17, —S(O)1-2R16, —S(O)1-2NR16R17, —NR16S(O)1-2R17, —NR16S(O)1-2NR16R17, —NR16C(O)R17, or —NR16C(O)OR17, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl of R17 is independently optionally substituted with one to five R12;
- each R12 is independently halo, cyano, nitro, oxo, —OR30, —SR30, —SF5, —NR30R31, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, heterocyclyl, aryl, heteroaryl, —C(O)R30, —C(O)OR30, —OC(O)OR30, —OC(O)R30, —C(O)NR30R31, —OC(O)NR30R31, —NR30C(O)NR3OR31, —S(O)1-2R30, —S(O)1-2NR30R31, —NR30S(O)1-2R31, —NR30S(O)1-2NR30R31, —NR30C(O)R31, or —NR30C(O)OR31, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl of R2 is independently optionally substituted with one to five halo or C1-12 alkyl independently optionally substituted by one to five oxo, halo, hydroxyl, or amino;
- each R13 is independently halo, cyano, nitro, oxo, —OR30, —SR30, —SF5, —NR30R31, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, heterocyclyl, aryl, heteroaryl, —C(O)R30, —C(O)OR30, —OC(O)OR30, —OC(O)R30, —C(O)NR30R31, —OC(O)NR30R31, —NR30C(O)NR30R31, —S(O)1-2R30, —S(O)1-2NR30R31, —NR30S(O)1-2R31, —NR30S(O)1-2NR30R31, —NR30C(O)R31, or —NR30C(O)OR31, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl of R13 is independently optionally substituted with one to five halo or C1-12 alkyl independently optionally substituted by one to five oxo, halo, hydroxyl, or amino;
- R16 and R17 are independently hydrogen, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, heterocyclyl, aryl, heteroaryl, —C(O)R20, —C(O)OR20, —C(O)NR20R21, —S(O)1-2R20 or —S(O)1-2NR20R21, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl of R16 and R17 are independently optionally substituted with one to five R12;
- or two R16, or R16 and R17, are taken together with the atoms to which they are attached to form a heterocyclyl independently optionally substituted by one to five halo, oxo, or C1-12 alkyl independently optionally substituted by one to five oxo, halo, hydroxyl, or amino;
- each R20 and R21 is independently hydrogen or C1-12 alkyl independently optionally substituted with one to five oxo, halo, hydroxyl, or amino;
- or R20 and R21 are taken together with the atoms to which they are attached to form heterocyclyl independently optionally substituted by one to five halo or C1-12 alkyl independently optionally substituted by one to five oxo, halo, hydroxyl, or amino;
- and
- each R30 and R31 is independently hydrogen or C1-12 alkyl independently optionally substituted with one to five oxo, halo, hydroxyl, or amino;
- or R30 and R31 are taken together with the atoms to which they are attached to form heterocyclyl independently optionally substituted by one to five halo or C1-12 alkyl independently optionally substituted by one to five oxo, halo, hydroxyl, or amino;
- provided that when z is 0 and X is a bond, then R1 and R2 are not both methyl or R3 is other than a bicyclic pyrrolidinyl ring substituted with one to six R11.
The compound of any preceding claim, wherein R1 and R2, together with the nitrogen atom to which they are attached, join to form a heterocyclyl or heteroaryl, each of which is optionally substituted with one to five R11.
The compound of any preceding claim, wherein R1 and R2, together with the nitrogen atom to which they are attached, join to form a heterocyclyl, which is optionally substituted with one to five R11.
The compound of any preceding claim, wherein R1 and R2, together with the nitrogen atom to which they are attached, join to form a heterocyclyl, which is optionally substituted with one to five substituents independently selected from the group consisting halo, —OR16, and C1-12 alkyl optionally substituted with one to five R12.
The compound of any preceding claim, wherein R1 and R2, together with the nitrogen atom to which they are attached, join to form a heterocyclyl, which is optionally substituted with one to five substituents independently selected from the group consisting of halo, C1-12 alkyl, C1-12 haloalkyl, —O—C1-12 alkyl, and —O—C1-12 haloalkyl.
The compound of any preceding claim, wherein R3 is aryl or heteroaryl, each of which is optionally substituted with one to five R11.
The compound of any preceding claim, wherein R3 is aryl or heteroaryl, each of which is optionally substituted with one to five substituents independently selected from halo, cyano, C1-12 haloalkyl, and C1-12 haloalkoxy.
The compound of any preceding claim, wherein R3 is aryl or heteroaryl, each of which is optionally substituted with chloro, fluoro, —CF3, or a combination thereof.
The compound of any preceding claim, wherein R3 is
- each of which is optionally substituted with one to five R11.
The compound of any preceding claim, wherein R3 is phenyl optionally substituted with one to five R11.
The compound of any preceding claim, wherein each R8 is independently halo, cyano, —NR16R17, C1-6 alkyl, C1-6 alkoxy, or C1-6 haloalkyl, or two R8 attached to the same atom, together form a C(O) or spiro C3-6 cycloalkyl, or two R8 attached to different atoms, together with the atoms to which they are attached, form a fused C3-6 cycloalkyl, wherein each C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, or C3-6 cycloalkyl of R8 is optionally substituted with one to six R10.
The compound of any preceding claim, wherein each R8 is independently halo.
The compound of any preceding claim, wherein p is 0, 1 or 2.
The compound of any preceding claim, wherein p is 0.
A compound selected from Table 1 or Table 2, or a pharmaceutically acceptable salt, isotopically enriched analog, stereoisomer, mixture of stereoisomers, or prodrug thereof.
A method of preparing a compound of Formula I, or a salt, isotopically enriched analog, stereoisomer, or mixture of stereoisomers thereof:
- comprising contacting a compound of Formula A:
- with a compound of formula HNR1R2, under conditions suitable to provide a compound of Formula I;
- wherein
- R100 is hydrogen or alkyl;
- p is 0, 1, 2, 3, 4, 5 or 6;
- L is heteroaryl optionally substituted with one to six R13, or a linker of Formula:
- where bond a is attached to the tetrahydropyran and bond b is attached to R3;
- X is O, NR7, or a bond;
- z is 0 or 1;
- R1 is C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl, each of which is optionally substituted with one to five R11;
- R2 is hydrogen, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl, each of which, other than hydrogen, is optionally substituted with one to five R11;
- or R1 and R2, together with the nitrogen atom to which they are attached, join to form a heterocyclyl or heteroaryl, each of which is optionally substituted with one to five R11;
- R3 is C3-10 cycloalkyl, heterocyclyl, aryl, or heteroaryl, each of which is optionally substituted with one to six R11;
- R4 and R5 are independently hydrogen, C1-12 alkyl, C2-12 alkenyl or C2-12 alkynyl, each of which, other than hydrogen, is independently optionally substituted with one to five R11;
- or R4 and R5, together with the atoms to which they are attached, join to form a C3-10 cycloalkyl or heterocyclyl, each of which is optionally substituted with one to five R11;
- R6 is hydrogen, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, or heterocyclyl, each of which, other than hydrogen, is optionally substituted with one to three R11;
- or R4 and R6, together with the atoms to which they are attached, join to form a C3-10 cycloalkyl or heterocyclyl, each of which is optionally substituted with one to five R11;
- R7 is hydrogen, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, or heterocyclyl, each of which, other than hydrogen, is optionally substituted with one to three R11;
- or R4 and R7, together with the atoms to which they are attached, join to form a C3-10 cycloalkyl or heterocyclyl, each of which is optionally substituted with one to five R11;
- each R8 is independently halo, cyano, —NR16R17, C1-6 alkyl, C1-6 alkoxy, or C1-6 haloalkyl, or two R8 attached to the same atom, together form a C(O) or spiro C3-6 cycloalkyl, or two R8 attached to different atoms, together with the atoms to which they are attached, form a fused C3-6 cycloalkyl or a C1-3 alkylene bridge, wherein each C1-6 alkyl, C1-6 alkoxy, C1-6 haloalkyl, C3-6 cycloalkyl or C1-3 alkylene bridge of R8 is optionally substituted with one to six R10;
- each R10 is independently halo, hydroxy, C1-6 alkyl, or C1-6 haloalkyl;
- each R11 is independently halo, cyano, nitro, oxo, —OR16, —SR16, —SF5, —NR16R17, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, heterocyclyl, aryl, heteroaryl, —C(O)R16, —C(O)OR16, —OC(O)OR16, —OC(O)R16, —C(O)NR16R17, —OC(O)NR16R17, —NR16C(O)NR16R17, —S(O)1-2R16, —S(O)1-2NR16R17, —NR16S(O)1-2R17, —NR16S(O)1-2NR16R17, —NR16C(O)R17, or —NR16C(O)OR17, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl of R11 is independently optionally substituted with one to five R12;
- each R12 is independently halo, cyano, nitro, oxo, —OR30, —SR30, —SF5, —NR30R31, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, heterocyclyl, aryl, heteroaryl, —C(O)R30, —C(O)OR30, —OC(O)OR30, —OC(O)R30, —C(O)NR30R31, —OC(O)NR30R31, —NR30C(O)NR3OR31, —S(O)1-2R30, —S(O)1-2NR30R31, —NR30S(O)1-2R31, —NR30S(O)1-2NR30R31, —NR30C(O)R31, or —NR30C(O)OR31, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl of R12 is independently optionally substituted with one to five halo or C1-12 alkyl independently optionally substituted by one to five oxo, halo, hydroxyl, or amino;
- each R13 is independently halo, cyano, nitro, oxo, —OR30, —SR30, —SF5, —NR30R31, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, heterocyclyl, aryl, heteroaryl, —C(O)R30, —C(O)OR30, —OC(O)OR30, —OC(O)R30, —C(O)NR30R31, —OC(O)NR30R31, —NR30C(O)NR30R31, —S(O)1-2R30, —S(O)1-2NR30R31, —NR30S(O)1-2R31, —NR30S(O)1-2NR30R31, —NR30C(O)R31, or —NR30C(O)OR31, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl of R13 is independently optionally substituted with one to five halo or C1-12 alkyl independently optionally substituted by one to five oxo, halo, hydroxyl, or amino;
- R16 and R17 are independently hydrogen, C1-12 alkyl, C2-12 alkenyl, C2-12 alkynyl, C3-10 cycloalkyl, heterocyclyl, aryl, heteroaryl, —C(O)R20, —C(O)OR20, —C(O)NR20R21, —S(O)1-2R20 or —S(O)1-2NR20R21, wherein each alkyl, alkenyl, alkynyl, cycloalkyl, heterocyclyl, aryl, and heteroaryl of R16 and R17 are independently optionally substituted with one to five R12;
- or two R16, or R16 and R17, are taken together with the atoms to which they are attached to form a heterocyclyl independently optionally substituted by one to five halo, oxo, or C1-12 alkyl independently optionally substituted by one to five oxo, halo, hydroxyl, or amino;
- each R20 and R21 is independently hydrogen or C1-12 alkyl independently optionally substituted with one to five oxo, halo, hydroxyl, or amino;
- or R20 and R21 are taken together with the atoms to which they are attached to form heterocyclyl independently optionally substituted by one to five halo or C1-12 alkyl independently optionally substituted by one to five oxo, halo, hydroxyl, or amino;
- and
- each R30 and R31 is independently hydrogen or C1-12 alkyl independently optionally substituted with one to five oxo, halo, hydroxyl, or amino;
- or R30 and R31 are taken together with the atoms to which they are attached to form heterocyclyl independently optionally substituted by one to five halo or C1-12 alkyl independently optionally substituted by one to six five, halo, hydroxyl, or amino.
Dependencies are inferred from the claim text.